CRISPR Therapeutics (CRSP) is soaring to new highs today. I last looked at CRSP back on October 5 and wrote that, "I am not yet convinced that CRSP can rally strongly BUT a close above $89 tells me that traders could go long risking a close below $80. Take profits around $102 if available."
More from Investing
There is hope that the worst is over for now, but the danger of failed bounces cannot be quickly dismissed.
If you had missed these last two days you may have missed 48 hours of the most important gains of the year.